Clinical Trial Update: Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing enteric-coated mycophenolate sodium to mycophenolate mofetil in adult de novo renal transplant patients, with the study status shown a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplant | Phase 3 | Status: COMPLETED